about
Nail PsoriasisPsoriasis pathophysiology: current concepts of pathogenesisImmune-directed therapy for type 1 diabetes at the clinical level: the Immune Tolerance Network (ITN) experiencePersonalized medicine in psoriasis: developing a genomic classifier to predict histological response to Alefacept.Biologics in dermatologic therapy - an update.Alefacept: a review of the literature and practical guidelines for management.The vertebral artery: a review of anatomical, histopathological and functional factors influencing blood flow to the hindbrain.Immune interventions to preserve β cell function in type 1 diabetesBiologic agents in psoriasis.Biologic therapeutics in the treatment of psoriasis. Part 1: review.Alefacept: its safety profile, off-label uses, and potential as part of combination therapies for psoriasis.Interleukin-20 as a target in psoriasis treatment.Targeting regulatory T cells in the treatment of type 1 diabetes mellitus.Targeting of memory T cells with alefacept in new-onset type 1 diabetes (T1DAL study): 12 month results of a randomised, double-blind, placebo-controlled phase 2 trial.Novel immunobiologics for psoriasis.A pharmacoeconomic analysis of severe psoriasis therapy: a review of treatment choices and cost efficiency.Targeting memory T cells in type 1 diabetes.Impact of Immune-Modulatory Drugs on Regulatory T Cell.A Study of Various Histopathological Features and their Relevance in Pathogenesis of Psoriasis.Current concepts in the pathogenesis of psoriasis.Cost-effectiveness and impact on quality of life of alefacept in the treatment of psoriasis.Effect of calcipotriol on epidermal cell populations in alefacept-treated psoriatic lesions.Psoriasis pathogenesis and the development of novel targeted immune therapies.
P2860
Q22305813-9AC57247-9411-4B06-BDF1-05DB1CA6BB6DQ24674984-E04508AF-BF2E-44A2-8D42-5D0361E1126EQ26850621-8953108A-1C21-45BD-AC69-122C7CFEBCC6Q33530942-B9A0ED1F-FB9F-40BA-A82D-536E12F35A69Q33607620-C23EE879-492A-44C0-BB03-4A66AD918397Q35893152-D4A43357-7B56-436D-B000-E35A32DDB3F8Q36356951-B8269BB9-5C44-48D3-8E74-D583612F633CQ36520618-C27AE7E6-D901-4039-821C-1C32C5713095Q36620700-7CDE4C8B-D1CB-4C44-A128-4FFD7CAB3CE0Q36826201-A96E5F04-CF2D-4B8E-950A-C3177046BF8DQ36900195-83A05A64-A540-40C7-A185-38AAAE5AB299Q36958344-2345F8F3-1EAF-4B0A-BEB5-215A1C07A756Q37006155-EA1B4C5B-8CAF-4A05-8ED4-CFB2BBB90EA1Q37642554-0DB18AD1-8A83-4012-B735-6BFA0C887566Q37664478-269ABA2F-016F-4586-81CD-84212B5F3718Q37898704-FFC37AB0-C509-4B62-9811-540A6A6657D4Q38586890-E4C31C67-346C-4554-BF1F-DA71175B0D1DQ38918124-03B32764-7B26-488A-99EB-A79740F977D5Q39372007-FEC9F999-C5D6-4DCD-9CF0-4FFA8223A286Q42283126-7E4FD483-9CE6-458D-B309-A8F4BE541196Q43042832-C723EBDA-FA8B-42E1-8772-78BCAE117592Q46888800-C410CFA3-EF38-4F5D-9209-B141A1123337Q47830025-30A5F2B3-3A65-4D33-AEF0-17B508F036A0
P2860
description
2003 nî lūn-bûn
@nan
2003 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Development and use of alefacept to treat psoriasis.
@ast
Development and use of alefacept to treat psoriasis.
@en
type
label
Development and use of alefacept to treat psoriasis.
@ast
Development and use of alefacept to treat psoriasis.
@en
prefLabel
Development and use of alefacept to treat psoriasis.
@ast
Development and use of alefacept to treat psoriasis.
@en
P356
P1476
Development and use of alefacept to treat psoriasis.
@en
P2093
Gerald G Krueger
Kristina P Callis
P304
P356
10.1016/MJD.2003.552
P407
P433
P577
2003-08-01T00:00:00Z